The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-((5-(5-bromo-2,4-dimethoxybenzylidene)-3-methyl-4-oxothiazolidin-2-ylidene)amino)benzoic acid ID: ALA425782
PubChem CID: 9511578
Max Phase: Preclinical
Molecular Formula: C20H17BrN2O5S
Molecular Weight: 477.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(OC)c(/C=C2\S/C(=N/c3ccc(C(=O)O)cc3)N(C)C2=O)cc1Br
Standard InChI: InChI=1S/C20H17BrN2O5S/c1-23-18(24)17(9-12-8-14(21)16(28-3)10-15(12)27-2)29-20(23)22-13-6-4-11(5-7-13)19(25)26/h4-10H,1-3H3,(H,25,26)/b17-9-,22-20+
Standard InChI Key: GVXOQTRNZPTULG-PAFNDRTPSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
2.8155 -7.4769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9882 -7.4626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5641 -8.1708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9660 -8.8937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7965 -8.9040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2169 -8.1952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7392 -8.1575 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3382 -7.4365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6885 -6.6854 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0844 -6.1236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6369 -6.5246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4781 -7.3341 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.3614 -6.1300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0654 -6.5601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7894 -6.1646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4929 -6.5940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4728 -7.4196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7433 -7.8140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0428 -7.3822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1839 -5.3046 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4982 -6.5275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0443 -8.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4476 -8.9239 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4660 -7.4951 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.7199 -8.6386 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
-4.1762 -7.8507 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.8092 -5.3398 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.9013 -7.4571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5334 -4.9446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13 14 1 0
3 7 1 0
14 15 2 0
3 4 2 0
15 16 1 0
7 8 2 0
16 17 2 0
8 9 1 0
17 18 1 0
18 19 2 0
19 14 1 0
4 5 1 0
10 20 2 0
2 3 1 0
9 21 1 0
5 6 2 0
9 10 1 0
10 11 1 0
22 23 1 0
22 24 2 0
6 22 1 0
11 12 1 0
18 25 1 0
12 8 1 0
17 26 1 0
6 1 1 0
15 27 1 0
11 13 2 0
26 28 1 0
1 2 2 0
27 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 477.34Molecular Weight (Monoisotopic): 476.0042AlogP: 4.40#Rotatable Bonds: 5Polar Surface Area: 88.43Molecular Species: ACIDHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.08CX Basic pKa: 2.35CX LogP: 4.11CX LogD: 1.12Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.64Np Likeness Score: -1.10
References 1. Dayam R, Aiello F, Deng J, Wu Y, Garofalo A, Chen X, Neamati N.. (2006) Discovery of small molecule integrin alphavbeta3 antagonists as novel anticancer agents., 49 (15): [PMID:16854058 ] [10.1021/jm051296s ]